Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-11

FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a new Levothyroxine sodium product from Fresenius Kabi USA, LLC under its Original Application. Levothyroxine is a thyroid hormone replacement …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

ORIG AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)